C. P. Day and O. P. James, Steatohepatitis: a tale of two "hits, Gastroenterology, vol.114, pp.842-845, 1998.

M. Y. Chung, S. F. Yeung, H. J. Park, J. S. Volek, and R. S. Bruno, Dietary ?-and ?-tocopherol supplementation attenuates lipopolysaccharide-induced oxidative stress and inflammatory-related responses in an obese mouse model of nonalcoholic steatohepatitis, J Nutr Biochem, vol.21, pp.1200-1206, 2010.

Y. H. Han, H. J. Kim, E. J. Kim, K. S. Kim, S. Hong et al., ROR? decreases oxidative stress through the induction of SOD2 and GPx1 expression and thereby protects against nonalcoholic steatohepatitis in mice, Antioxid & Redox Signaling, vol.21, pp.2083-2094, 2014.

K. L. Thomsen, L. Hebbard, E. Glavind, A. Clouston, H. Vilstrup et al., Nonalcoholic steatohepatitis weakens the acute phase response to endotoxin in rats, Liver Int, vol.34, pp.1584-1592, 2014.

S. Sakaguchi, S. Takahashi, T. Sasaki, T. Kumagai, and K. Nagata, Progression of alcoholic and nonalcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress, Drug Metab Pharmacokinet, vol.26, pp.30-46, 2011.

K. Imajo, M. Yoneda, Y. Ogawa, K. Wada, and A. Nakajima, Microbiota and nonalcoholic steatohepatitis, Semin Immunopathol, vol.36, pp.115-132, 2014.

J. Boursier, O. Mueller, M. Barret, M. Machado, L. Fizanne et al., The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota, Hepatology, vol.63, pp.764-775, 2016.

A. R. Moschen, S. Kaser, and H. Tilg, Non-alcoholic steatohepatitis: a microbiota-driven disease, Trend Endocrinol Metab, vol.24, pp.537-545, 2013.
DOI : 10.1016/j.tem.2013.05.009

E. M. Quigley, C. Stanton, and E. F. Murphy, The gut microbiota and the liver. Pathophysiological and clinical implications, J Hepatol, vol.58, pp.1020-1027, 2013.

J. W. Mao, H. Y. Tang, T. Zhao, X. Y. Tan, J. Bi et al., Intestinal mucosal barrier dysfunction participates in the progress of nonalcoholic fatty liver disease, Int J Clin Exp Pathol, vol.8, pp.3648-3658, 2015.

S. Q. Yang, H. Z. Lin, M. D. Lane, M. Clemens, and A. M. Dieh, Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis, Proc Nat Acad Sci, vol.94, pp.2557-2562, 1997.

Z. Li, S. Yang, H. Lin, J. Huang, P. A. Watkins et al., Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease, Hepatology, vol.37, pp.343-350, 2003.
DOI : 10.1053/jhep.2003.50048
URL : https://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1053/jhep.2003.50048

W. Z. Mehal, The Gordian Knot of dysbiosis, obesity and NAFLD, Nat Rev Gastroenterol Hepatol, vol.10, pp.637-644, 2013.

J. Du-plessis, H. Korf, J. Van-pelt, P. Windmolders, V. Elst et al., Pro-Inflammatory cytokines but not endotoxin-related parameters associate with disease severity in patients with NAFLD, PLoS One, vol.11, p.16604, 2016.

H. Kitabatake, N. Tanaka, N. Fujimori, M. Komatsu, A. Okubo et al., Association between endotoxemia and histological features of nonalcoholic fatty liver disease, World J Gastroenterol, vol.23, pp.712-722, 2017.

M. Mouzaki, E. M. Comelli, B. M. Arendt, J. Bonengel, S. K. Fung et al., Intestinal microbiota in patients with nonalcoholic fatty liver disease, Hepatology, vol.58, pp.120-127, 2013.

D. Chierico, F. Gnani, D. Vernocchi, P. Petrucca, A. Alisi et al., Meta-omic platforms to assist in the understanding of NAFLD gut microbiota alterations: tools and applications, Int J Mol Sci, vol.15, pp.684-711, 2014.

A. Goel, M. Gupta, and R. Aggarwal, Gut microbiota and liver disease, J Gastroenterol Hepatol, vol.29, pp.1139-1148, 2014.
DOI : 10.1111/jgh.12556
URL : https://onlinelibrary.wiley.com/doi/pdf/10.1111/jgh.12556

T. Duparc, H. Plovier, V. G. Marrachelli, M. Van-hul, A. Essaghir et al., Hepatocyte MyD88 affects bile acids, gut microbiota and metabolome contributing to regulate glucose and lipid metabolism, Gut, vol.66, pp.620-632, 2017.
DOI : 10.1136/gutjnl-2015-310904
URL : https://gut.bmj.com/content/66/4/620.full.pdf

K. Imajo, K. Fujita, M. Yoneda, Y. Nozaki, Y. Ogawa et al., Hyperresponsivity to lowdose endotoxin during progression to nonalcoholic steatohepatitis is regulated by leptin-mediated signaling, Cell Metab, vol.16, pp.44-54, 2012.

H. Kawaratani, T. Tsujimoto, T. Kitazawa, M. Kitade, H. Yoshiji et al., Innate immune reactivity of the liver in rats fed a choline-deficient L-amino-acid-defined diet, World J Gastroenterol, vol.14, pp.6655-6661, 2008.

M. V. Machado and H. Cortez-pinto, Gut microbiota and nonalcoholic fatty liver disease, Ann Hepatol, vol.11, pp.440-449, 2012.

S. Guo, R. Al-sadi, H. M. Said, and T. Y. Ma, Lipopolysaccharide causes an increase in intestinal tight junction permeability in vitro and in vivo by inducing enterocyte membrane expression and localization of TLR4 and CD14, Am J Pathol, vol.182, pp.375-387, 2013.

J. P. Pradere, J. S. Troeger, D. H. Dapito, A. A. Mencin, and R. F. Schwabe, Toll-like receptor 4 and hepatic fibrogenesis, Semin Liver Dis, vol.30, pp.232-244, 2010.
DOI : 10.1055/s-0030-1255353
URL : http://europepmc.org/articles/pmc4099360?pdf=render

H. Tilg and A. R. Moschen, Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis, Hepatology, vol.52, pp.1836-1846, 2010.

Y. Ogawa, K. Imajo, M. Yoneda, T. Kessoku, W. Tomeno et al., Soluble CD14 levels reflect liver inflammation in patients with nonalcoholic steatohepatitis, PLoS One, vol.8, p.65211, 2013.

G. Szabo, A. Velayudham, L. Romics, and P. Mandrekar, Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice: the role of toll-like receptors 2 and 4, Alcohol Clin Exp Res, vol.29, pp.140-145, 2005.

K. Achiwa, M. Ishigami, Y. Ishizu, T. Kuzuya, T. Honda et al., DSS colitis promotes tumorigenesis and fibrogenesis in a choline-deficient high-fat diet-induced NASH mouse model, Biochem Biophys Res Commun, vol.470, pp.15-21, 2016.

E. Gäbele, K. Dostert, C. Hofmann, R. Wiest, J. Schölmerich et al., DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH, J Hepatol, vol.55, pp.1391-1399, 2011.

H. Kudo, T. Takahara, Y. Yata, K. Kawai, W. Zhang et al., Lipopolysaccharide triggered TNF-alphainduced hepatocyte apoptosis in a murine nonalcoholic steatohepatitis model, J Hepatol, vol.51, pp.168-175, 2009.

A. Alisi, M. Manco, R. Devito, F. Piemonte, and V. Nobili, Endotoxin and plasminogen activator inhibitor-1 serum levels associated with nonalcoholic steatohepatitis in children, J Pediatr Gastroenterol Nutr, vol.50, pp.645-649, 2010.

S. Ceccarelli, N. Panera, M. Mina, D. Gnani, D. Stefanis et al., LPS-induced TNF-? factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease, Oncotarget, vol.6, pp.41434-41452, 2015.

D. G. Duman, F. Ozdemir, E. Birben, O. Keskin, E. Ek?io?lu-demiralp et al., Effects of pentoxifylline on TNF-alpha production by peripheral blood mononuclear cells in patients with nonalcoholic steatohepatitis, Dig Dis Sci, vol.52, pp.2520-2524, 2007.

R. Kirsch, V. Clarkson, R. C. Verdonk, A. D. Marais, E. G. Shephard et al., Rodent nutritional model of steatohepatitis: effects of endotoxin (lipopolysaccharide) and tumor necrosis factor alpha deficiency, J Gastroenterol Hepatol, vol.21, pp.174-182, 2006.

J. Delarue and J. P. Lallès, Nonalcoholic fatty liver disease: Roles of the gut and the liver and metabolic modulation by some dietary factors and especially long-chain n-3 PUFA, Mol Nutr Food Res, vol.60, pp.147-159, 2016.

N. Matsushita, T. Osaka, I. Haruta, H. Ueshiba, N. Yanagisawa et al., Effect of lipopolysaccharide on the progression of non-alcoholic fatty liver disease in high caloric diet-fed mice, Scand J Immunol, vol.83, pp.109-118, 2015.

M. E. Dumas, R. H. Barton, A. Toye, O. Cloarec, C. Blancher et al., Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistance mice, Proc Nat Acad Sci, vol.103, pp.12511-12516, 2006.

M. D. Spencer, T. J. Hamp, R. W. Reid, L. M. Fischer, S. H. Zeisel et al., Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency, Gastroenterology, vol.140, pp.976-986, 2011.

M. Pawlak, E. Baugé, W. Bourguet, D. Bosscher, K. Lalloyer et al., The transrepressive activity of peroxisome proliferator-activated receptor alpha is necessary and sufficient to prevent liver fibrosis in mice, Hepatology, vol.60, pp.1593-1596, 2014.

P. Jha, T. Claudel, A. Baghdasaryan, M. Mueller, E. Halilbasic et al., Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia, Hepatology, vol.59, pp.858-869, 2014.

H. Okubo, A. Kushiyama, H. Sakoda, Y. Nakatsu, M. Iizuka et al., Involvement of resistin-like molecule ? in the development of methionine-choline deficient diet-induced non-alcoholic steatohepatitis in mice, Sci Rep, vol.6, 2016.

S. Anavi, M. Hahn-obercyger, M. R. Madar, Z. Tirosh, and O. , A novel antihypoglycemic role of inducible nitric oxide synthase in liver inflammatory response induced by dietary cholesterol and endotoxemia, Antioxid Redox Signal, vol.19, pp.1889-1901, 2013.

A. Leroux, G. Ferrere, V. Godie, F. Cailleux, M. L. Renoud et al., Toxic lipids stored by Kupffer cells correlates with their pro-inflammatory phenotype at an early stage of steatohepatitis, J Hepatol, vol.57, pp.141-149, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01004738

P. D. Cani, J. Amar, M. A. Iglesias, M. Poggi, C. Knauf et al., Metabolic endotoxemia initiates obesity and insulin resistance, Diabetes, vol.56, pp.1761-1772, 2007.

L. Etienne-mesmin, M. Vijay-kumar, A. T. Gewirtz, and B. Chassaing, Hepatocyte Toll-Like Receptor 5 promotes bacterial clearance and protects mice against high-fat diet-induced liver disease, Cell Mol Gastroenterol Hepatol, vol.2, pp.584-604, 2016.

G. Xie, X. Wang, P. Liu, R. Wei, W. Chen et al., Distinctly altered gut microbiota in the progression of liver disease, Oncotarget, vol.7, pp.19355-19366, 2016.

R. E. Ley, F. Bäckhed, P. Turnbaugh, C. A. Lozupone, R. D. Knight et al., Obesity alters gut microbial ecology, Proc Nat Acad Sci, vol.102, pp.11070-11075, 2005.
DOI : 10.1073/pnas.0504978102
URL : http://www.pnas.org/content/102/31/11070.full.pdf

R. E. Ley, P. J. Turnbaugh, S. Klein, and J. I. Gordon, Microbial ecology: human gut microbes associated with obesity, Nature, vol.444, pp.1022-1023, 2006.

P. J. Turnbaugh, R. E. Ley, M. A. Mahowald, V. Magrini, E. R. Mardis et al., An obesity-associated gut microbiome with increased capacity for energy harvest, Nature, vol.444, pp.1027-1031, 2006.

Y. Cao, Q. Pan, W. Cai, F. Shen, G. Y. Chen et al., Modulation of gut microbiota by Berberine improves steatohepatitis in high-fat diet-fed BALB/C mice, Arch Iran Med, vol.19, pp.197-203, 2016.

W. Liang, J. H. Lindeman, A. L. Menke, D. P. Koonen, M. Morrison et al., Metabolically induced liver inflammation leads to NASH and differs from LPS-or IL-1?-induced chronic inflammation, Lab Invest, vol.94, pp.491-502, 2014.
DOI : 10.1038/labinvest.2014.11
URL : https://www.nature.com/articles/labinvest201411.pdf

D. Zhou, Q. Pan, F. Shen, H. X. Cao, W. J. Ding et al., Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota, Sci Rep, vol.7, p.1529, 2017.

J. H. Guo, D. W. Han, X. Q. Li, Y. Zhang, and Y. C. Zhao, The impact of small doses of LPS on NASH in high sucrose and high fat diet induced rats, Eur Rev Med Pharmacol Sci, vol.18, pp.2742-2747, 2014.

S. Fukunishi, H. Nishio, A. Fukuda, A. Takeshita, T. Hanafusa et al., Development of fibrosis in nonalcoholic steatosis through combination of a synthetic diet rich in disaccharide and lowdose lipopolysaccharides in the livers of Zucker (fa/fa) rats, J Clin Biochem Nutr, vol.45, pp.322-328, 2009.

K. Kavanagh, A. T. Wylie, K. L. Tucker, T. J. Hamp, R. Z. Gharaibeh et al., Dietary fructose induces endotoxemia and hepatic injury in calorically controlled primates, Am J Clin Nutr, vol.98, pp.349-357, 2013.
DOI : 10.3945/ajcn.112.057331
URL : https://academic.oup.com/ajcn/article-pdf/98/2/349/23828792/349.pdf

M. Kobori, Y. Ni, Y. Takahashi, N. Watanabe, M. Sugiura et al., ) ?-Cryptoxanthin alleviates diet-induced nonalcoholic steatohepatitis by suppressing inflammatory gene expression in mice, PLoS One, vol.9, p.98294, 2014.
DOI : 10.1371/journal.pone.0098294
URL : https://doi.org/10.1371/journal.pone.0098294

E. Seki, D. Minicis, S. Osterreicher, C. H. Kluwe, J. Osawa et al., TLR4 enhances TGF-beta signaling and hepatic fibrosis, Nat Med, vol.13, pp.1324-1332, 2007.
DOI : 10.1038/nm1663

J. Guo and S. L. Friedman, Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis, Fibrogenesis Tissue Repair, vol.3, p.21, 2010.
DOI : 10.1186/1755-1536-3-21
URL : https://fibrogenesis.biomedcentral.com/track/pdf/10.1186/1755-1536-3-21

F. Marra and S. Lotersztajn, Pathophysiology of NASH: perspectives for a targeted treatment, Curr Pharm Des, vol.19, pp.5250-5269, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00801356

J. Boeckmans, A. Natale, K. Buyl, V. Rogiers, D. Kock et al., Humanbased systems: Mechanistic NASH modelling just around the corner?, Pharmacol Res, vol.134, pp.257-267, 2018.
DOI : 10.1016/j.phrs.2018.06.029
URL : https://doi.org/10.1016/j.phrs.2018.06.029

Y. Tang, Z. Bian, L. Zhao, Y. Liu, S. Liang et al., Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease, Clin Exp Immunol, vol.166, pp.281-290, 2011.

A. Caligiuri, A. Gentilini, and F. Marra, Molecular pathogenesis of NASH, Int J Mol Sci, vol.20, p.17, 2016.
DOI : 10.3390/ijms17091575
URL : https://www.mdpi.com/1422-0067/17/9/1575/pdf

J. Henao-mejia, E. Elinav, J. C. Hao, L. Mehal, W. Z. Strowig et al., Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity, Nature, vol.482, pp.179-185, 2012.
DOI : 10.1038/nature10809
URL : http://europepmc.org/articles/pmc3276682?pdf=render

T. Csak, M. Ganz, J. Pespisa, K. Kodys, A. Dolganiuc et al., Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells, Hepatology, vol.54, pp.133-144, 2011.
DOI : 10.1002/hep.24341
URL : https://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.24341

W. Liu, R. D. Baker, T. Bhatia, L. Zhu, and S. S. Baker, Pathogenesis of nonalcoholic steatohepatitis, Cell Mol Life Sci, vol.73, pp.1969-1987, 2016.

P. Vernia, A. Marcheggiano, R. Caprilli, G. Frieri, G. Corrao et al., Shortchain fatty acid topical treatment in distal ulcerative colitis, Aliment Pharmacol Therap, vol.9, pp.309-313, 1995.

K. M. Maslowski, A. T. Vieira, A. Ng, J. Kranich, F. Sierro et al., Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43, Nature, vol.461, pp.1282-1286, 2009.

L. Zhu, R. D. Baker, and S. S. Baker, Gut microbiome and nonalcoholic fatty liver diseases, Pediatr Res, vol.77, pp.245-251, 2015.

B. L. Copple and T. Li, Pharmacology of bile acid receptors: Evolution of bile acids from simple detergents to complex signaling molecules, Pharmacol Res, vol.104, pp.9-21, 2016.

Y. Zhu, F. Li, and G. L. Guo, Tissue-specific function of farnesoid X receptor in liver and intestine, Pharmacol Res, vol.63, issue.4, pp.259-265, 2011.

G. Brandi, D. Lorenzo, S. Candela, M. Pantaleo, M. A. Bellentani et al., Microbiota, NASH, HCC and the potential role of probiotics, vol.38, pp.231-240, 2017.

B. Kong, J. P. Luyendyk, O. Tawfik, and G. L. Guo, Farnesoid X receptor deficiency induces nonalcoholic steatohepatitis in low-density lipoprotein receptor-knockout mice fed a high-fat diet, J Pharmacol Exp Ther, vol.328, pp.116-122, 2009.

R. H. Mcmahan, X. X. Wang, L. L. Cheng, T. Krisko, M. Smith et al., Bile acid receptor activation modulates hepatic monocyte activity and improves nonalcoholic fatty liver disease, J Biol Chem, vol.288, pp.11761-11770, 2013.

T. R. Haque and . Barritt, Intestinal microbiota in liver disease, Best Pract Res Clin Gastroenterol, vol.4, pp.133-142, 2016.

A. Federico, M. Dallio, J. Godos, C. Loguercio, and F. Salomone, Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidence, Transl Res, vol.167, pp.116-124, 2016.

S. Fiorucci, M. Biagioli, and E. Distrutti, Future trends in the treatment of non-alcoholic steatohepatitis, Pharmacol Res, vol.134, pp.289-298, 2018.

B. A. Runyon, A pill a day can improve survival in patients with advanced cirrhosis, Gastroenterology, vol.133, pp.1029-1031, 2007.

Q. Zhu, L. Zou, K. Jagavelu, D. A. Simonetto, R. C. Huebert et al., Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice, J Hepatol, vol.56, pp.893-899, 2012.

J. Fernández, M. Navasa, R. Planas, S. Montoliu, D. Monfort et al., Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis, Gastroenterology, vol.133, pp.818-824, 2007.

P. D. Cani, S. Possemiers, T. Van-de-wiele, Y. Guiot, E. A. Rottier et al., Changes in gut microbiota control metabolic endotoxemia induced inflammation in high-fat diet-induced obesity and diabetes in mice, Diabetes, vol.57, pp.1470-1481, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00410066

E. J. Drenick, J. Fisler, and D. Johnson, Hepatic steatosis after intestinal bypass. Prevention and reversal by metronidazole, irrespective of protein calorie malnutrition, Gastroenterology, vol.82, pp.535-548, 1982.

I. Bergheim, S. Weber, M. Vos, S. Krämer, V. Volynets et al., Antibiotics protect against fructose induced hepatic lipid accumulation in mice: role of endotoxin, J Hepatol, vol.48, pp.983-992, 2008.

S. N. Lichtman, J. Keku, J. H. Schwab, and R. B. Sartor, Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline, Gastroenterology, vol.100, pp.513-519, 1991.

S. Yamada, N. Kamada, T. Amiya, N. Nakamoto, T. Nakaoka et al., Gut microbiota-mediated generation of saturated fatty acids elicits inflammation in the liver in murine high-fat dietinduced steatohepatitis, BMC Gastroenterol, vol.29, p.136, 2017.

V. Gangarapu, A. T. Ince, B. Baysal, Y. Kayar, U. K?l?ç et al., Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease, Eur J Gastroenterol Hepatol, vol.27, pp.840-845, 2015.

A. Douhara, K. Moriya, H. Yoshiji, R. Noguchi, T. Namisaki et al., Reduction of endotoxin attenuates liver fibrosis through suppression of hepatic stellate cell activation and remission of intestinal permeability in a rat non-alcoholic steatohepatitis model, Mol Med Rep, vol.11, pp.1693-1700, 2015.

M. Membrez, F. Blancher, M. Jaquet, R. Bibiloni, P. D. Cani et al., Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice, FASEB J, vol.22, pp.2416-2426, 2008.
URL : https://hal.archives-ouvertes.fr/inserm-00409179

J. Fernández, P. Tandon, J. Mensa, and G. Garcia-tsao, Antibiotic prophylaxis in cirrhosis: Good and bad, Hepatology, vol.63, issue.6, pp.2019-2031, 2016.

D. Adawi, F. B. Kasravi, G. Molin, and B. Jeppsson, Effect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat, Hepatology, vol.25, pp.642-647, 1997.

C. Loguercio, D. Simone, T. Federico, A. Terracciano, F. Tuccillo et al., Gut-liver axis: a new point of attack to treat chronic liver damage?, Am J Gastroenterol, vol.97, pp.2144-2146, 2002.

N. Osman, D. Adawi, S. Ahrné, B. Jeppsson, and G. Molin, Endotoxin-and D-galactosamine-induced liver injury improved by the administration of Lactobacillus, Bifidobacterium and blueberry, Dig Liv Dis, vol.39, pp.849-856, 2007.

J. Ewaschuk, R. Endersby, D. Thiel, H. Diaz, J. Backer et al., Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis, Hepatology, vol.46, pp.841-85, 2007.

R. Kelishadi, S. Farajian, and M. Mirlohi, Probiotics as a novel treatment for non-alcoholic fatty liver disease; a systematic review on the current evidences, Hepat Mon, vol.13, p.7233, 2013.

L. Xue, J. He, N. Gao, X. Lu, M. Li et al., Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia, Sci Rep, vol.7, p.45176, 2017.

R. Aller, D. Luis, D. A. Izaola, O. Conde, R. et al., Effect of a probiotic on liver aminotransferases in nonalcoholic fatty liver disease patients: a double blind randomized clinical trial, Eur Rev Med Pharmacol Sci, vol.9, pp.1090-1095, 2011.

C. Loguercio, A. Federico, C. Tuccillo, F. Terracciano, D. 'auria et al., Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases, J Clin Gastroenterol, vol.39, pp.540-543, 2005.

A. Velayudham, A. Dolganiuc, M. Ellis, J. Petrasek, K. Kodys et al., VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice, Hepatology, vol.49, pp.989-997, 2009.

S. F. Solga, G. Buckley, J. M. Clark, A. Horska, and A. M. Diehl, The effect of a probiotic on hepatic steatosis, J Clin Gastroenterol, vol.42, issue.10, pp.1117-1119, 2008.

E. Esposito, A. Iacono, G. Bianco, G. Autore, S. Cuzzocrea et al., Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats, J Nutr, vol.139, pp.905-911, 2009.

A. Mencarelli, S. Cipriani, B. Renga, A. Bruno, D. 'amore et al., VSL#3 resets insulin signaling and protects against NASH and atherosclerosis in a model of genetic dyslipidemia and intestinal inflammation, PLoS One, vol.7, p.45425, 2012.

R. K. Dhiman, R. B. Agrawal, S. Garg, A. Chopra, M. Thumburu et al., Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, Gastroenterology, vol.147, pp.1327-1337, 2014.

S. Wagnerberger, A. Spruss, G. Kanuri, C. Stahl, M. Schröder et al., Lactobacillus casei Shirota protects from fructose-induced liver steatosis: a mouse model, J Nutr Biochem, vol.24, pp.531-538, 2012.

H. Okubo, H. Sakoda, A. Kushiyama, M. Fujishiro, Y. Nakatsu et al., Lactobacillus casei strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model, Am J Physiol Gastrointest Liver Physiol, vol.305, pp.911-918, 2013.

Y. Ritze, G. Bárdos, C. A. Ehrmann, V. Bergheim, I. Schwiertz et al., Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice, PLoS One, vol.27, issue.1, p.80169, 2014.

E. Manzhalii, O. Virchenko, T. Falalyeyeva, T. Beregova, and W. Stremmel, Treatment efficacy of a probiotic preparation for non-alcoholic steatohepatitis: A pilot trial, J Dig Dis, vol.18, issue.12, pp.698-703, 2017.

M. B. Roberfroid, Prebiotics and probiotics: are they functional foods?, Am J Clin Nutr, vol.71, pp.1682-1687, 2000.

J. A. Parnell, M. Raman, K. P. Rioux, and R. A. Reimer, The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance, Liver Int, vol.32, pp.701-711, 2012.

C. A. Daubioul, H. S. Taper, L. D. De-wispelaere, and N. M. Delzenne, Dietary oligofructose lessens hepatic steatosis, but does not prevent hypertriglyceridemia in obese zucker rats, J Nutr, vol.130, pp.1314-1319, 2000.

B. D. Pachikian, A. Essaghir, J. B. Demoulin, E. Catry, A. M. Neyrinck et al., Prebiotic approach alleviates hepatic steatosis: Implication of fatty acid oxidative and cholesterol synthesis pathways, Mol Nutr Food Res, vol.7, pp.347-359, 2013.

M. Malaguarnera, M. Vacante, T. Antic, M. Giordano, G. Chisari et al., Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis, Dig Dis Sci, vol.57, pp.545-553, 2012.

C. A. Daubioul, Y. Horsmans, P. Lambert, E. Danse, and N. M. Delzenne, Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study, Eur J Clin Nutr, vol.59, pp.723-726, 2005.

S. M. Ferolla, C. A. Couto, L. Costa-silva, G. N. Armiliato, C. A. Pereira et al., Beneficial effect of synbiotic supplementation on hepatic steatosis and anthropometric parameters, but not on gut permeability in a population with nonalcoholic steatohepatitis, Nutrients, vol.28, issue.7, p.8, 2016.

J. Busserolles, E. Gueux, E. Rock, C. Demigné, A. Mazur et al., Oligofructose protects against the hypertriglyceridemic and pro-oxidative effects of a high fructose diet in rats, J Nutr, vol.133, pp.1903-1908, 2003.

P. D. Cani, S. Possemiers, T. Van-de-wiele, Y. Guiot, E. A. Rottier et al., Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability, Gut, vol.58, pp.1091-1103, 2009.

E. M. Brunt, C. G. Janney, D. Bisceglie, A. M. Neuschwander-tetri, B. A. Bacon et al., Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions, Am J Gastroenterol, vol.94, issue.9, pp.2467-2474, 1999.

Y. H. Paik, R. F. Schwabe, R. Bataller, M. P. Russo, C. Jobin et al., Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells, Hepatology, vol.37, pp.1043-1055, 2003.

F. Wang, S. Liu, D. T. Chen, H. Li, Z. Yan et al., NF-?B inhibition alleviates carbon tetrachlorideinduced liver fibrosis via suppression of activated hepatic stellate cells, Exp Ther Med, vol.8, issue.1, pp.95-99, 2014.

W. X. Zhao, L. Wang, J. L. Yang, L. Z. Li, W. M. Xu et al., Caffeic acid phenethyl ester attenuates proinflammatory and fibrogenic phenotypes of LPS-stimulated hepatic stellate cells through the inhibition of NF-?B signaling, Int J Mol Med, vol.33, issue.3, pp.687-694, 2014.

H. Sprenger, A. Kaufmann, H. Garn, B. Lahme, D. Gemsa et al., Differential expression of monocyte chemotactic protein-1 (MCP-1) in transforming rat hepatic stellate cells, J Hepatol, vol.30, issue.1, pp.88-94, 1999.

S. Kumar, J. Wang, S. K. Shanmukhappa, and C. R. Gandhi, Toll-like receptor 4-independent carbon tetrachlorideinduced fibrosis and lipopolysaccharide-induced acute liver injury in mice: Role of hepatic stellate cells, Am J Pathol, vol.187, pp.1356-1367, 2017.

W. Dornas, D. Glaise, A. Bodin, A. Sharanek, A. Burban et al., Endotoxin regulates matrix genes increasing reactive oxygen species generation by intercellular communication between palmitate-treated hepatocyte and stellate cell, J Cell Physiol, vol.234, issue.1, pp.122-133, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01880153